vs

Side-by-side financial comparison of APPLIED INDUSTRIAL TECHNOLOGIES INC (AIT) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

APPLIED INDUSTRIAL TECHNOLOGIES INC is the larger business by last-quarter revenue ($1.3B vs $719.4M, roughly 1.7× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 8.0%, a 65.2% gap on every dollar of revenue. On growth, APPLIED INDUSTRIAL TECHNOLOGIES INC posted the faster year-over-year revenue change (7.3% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $95.4M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 3.8%).

Applied Industrial Technologies, Inc. (AIT) is a public, global company based in the U.S. and focused on the distribution of bearings, power transmission products, engineered fluid power components and systems, specialty flow control products, and other industrial supplies. AIT provides engineering, design and system integration for industrial and fluid power applications, as well as customized mechanical, fabricated rubber, fluid power, and flow control shop services.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

AIT vs DOC — Head-to-Head

Bigger by revenue
AIT
AIT
1.7× larger
AIT
$1.3B
$719.4M
DOC
Growing faster (revenue YoY)
AIT
AIT
+4.2% gap
AIT
7.3%
3.1%
DOC
Higher net margin
DOC
DOC
65.2% more per $
DOC
73.2%
8.0%
AIT
More free cash flow
DOC
DOC
$261.6M more FCF
DOC
$357.0M
$95.4M
AIT
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
3.8%
AIT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
AIT
AIT
DOC
DOC
Revenue
$1.3B
$719.4M
Net Profit
$99.8M
$114.0M
Gross Margin
30.4%
Operating Margin
11.0%
17.4%
Net Margin
8.0%
73.2%
Revenue YoY
7.3%
3.1%
Net Profit YoY
-0.0%
2406.4%
EPS (diluted)
$2.65
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AIT
AIT
DOC
DOC
Q1 26
$1.3B
Q4 25
$1.2B
$719.4M
Q3 25
$1.2B
$705.9M
Q2 25
$1.2B
$694.3M
Q1 25
$1.2B
$702.9M
Q4 24
$1.1B
$698.0M
Q3 24
$1.1B
$700.4M
Q2 24
$1.2B
$695.5M
Net Profit
AIT
AIT
DOC
DOC
Q1 26
$99.8M
Q4 25
$95.3M
$114.0M
Q3 25
$100.8M
$-117.1M
Q2 25
$107.8M
$31.7M
Q1 25
$99.8M
$42.8M
Q4 24
$93.3M
$4.5M
Q3 24
$92.1M
$85.9M
Q2 24
$103.5M
$146.0M
Gross Margin
AIT
AIT
DOC
DOC
Q1 26
30.4%
Q4 25
30.4%
Q3 25
30.1%
58.6%
Q2 25
30.6%
60.2%
Q1 25
30.5%
61.1%
Q4 24
30.6%
60.3%
Q3 24
29.6%
60.0%
Q2 24
30.7%
60.6%
Operating Margin
AIT
AIT
DOC
DOC
Q1 26
11.0%
Q4 25
10.6%
17.4%
Q3 25
10.8%
9.2%
Q2 25
11.0%
5.7%
Q1 25
11.1%
7.7%
Q4 24
11.3%
-2.2%
Q3 24
10.3%
14.1%
Q2 24
12.0%
22.3%
Net Margin
AIT
AIT
DOC
DOC
Q1 26
8.0%
Q4 25
8.2%
73.2%
Q3 25
8.4%
-16.6%
Q2 25
8.8%
4.6%
Q1 25
8.6%
6.1%
Q4 24
8.7%
0.7%
Q3 24
8.4%
12.3%
Q2 24
8.9%
21.0%
EPS (diluted)
AIT
AIT
DOC
DOC
Q1 26
$2.65
Q4 25
$2.51
$0.16
Q3 25
$2.63
$-0.17
Q2 25
$2.80
$0.05
Q1 25
$2.57
$0.06
Q4 24
$2.39
$0.02
Q3 24
$2.36
$0.12
Q2 24
$2.64
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AIT
AIT
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$171.6M
$467.5M
Total DebtLower is stronger
$365.3M
$9.8B
Stockholders' EquityBook value
$1.9B
$7.5B
Total Assets
$3.0B
$20.3B
Debt / EquityLower = less leverage
0.20×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AIT
AIT
DOC
DOC
Q1 26
$171.6M
Q4 25
$406.0M
$467.5M
Q3 25
$418.7M
$91.0M
Q2 25
$388.4M
$89.4M
Q1 25
$352.8M
$70.6M
Q4 24
$303.4M
$119.8M
Q3 24
$538.5M
$180.4M
Q2 24
$460.6M
$106.9M
Total Debt
AIT
AIT
DOC
DOC
Q1 26
$365.3M
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Stockholders' Equity
AIT
AIT
DOC
DOC
Q1 26
$1.9B
Q4 25
$1.9B
$7.5B
Q3 25
$1.9B
$7.6B
Q2 25
$1.8B
$7.9B
Q1 25
$1.8B
$8.2B
Q4 24
$1.8B
$8.4B
Q3 24
$1.8B
$8.6B
Q2 24
$1.7B
$8.8B
Total Assets
AIT
AIT
DOC
DOC
Q1 26
$3.0B
Q4 25
$3.2B
$20.3B
Q3 25
$3.2B
$19.6B
Q2 25
$3.2B
$19.8B
Q1 25
$3.1B
$19.8B
Q4 24
$3.0B
$19.9B
Q3 24
$3.0B
$20.0B
Q2 24
$3.0B
$20.2B
Debt / Equity
AIT
AIT
DOC
DOC
Q1 26
0.20×
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AIT
AIT
DOC
DOC
Operating Cash FlowLast quarter
$319.1M
$1.3B
Free Cash FlowOCF − Capex
$95.4M
$357.0M
FCF MarginFCF / Revenue
7.6%
49.6%
Capex IntensityCapex / Revenue
1.5%
124.4%
Cash ConversionOCF / Net Profit
3.20×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$438.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AIT
AIT
DOC
DOC
Q1 26
$319.1M
Q4 25
$99.7M
$1.3B
Q3 25
$119.3M
$315.0M
Q2 25
$147.0M
$363.5M
Q1 25
$122.5M
$279.4M
Q4 24
$95.1M
$1.1B
Q3 24
$127.7M
$318.2M
Q2 24
$119.2M
$316.2M
Free Cash Flow
AIT
AIT
DOC
DOC
Q1 26
$95.4M
Q4 25
$93.4M
$357.0M
Q3 25
$112.0M
Q2 25
$138.2M
Q1 25
$114.9M
Q4 24
$89.9M
$333.7M
Q3 24
$122.2M
Q2 24
$111.7M
FCF Margin
AIT
AIT
DOC
DOC
Q1 26
7.6%
Q4 25
8.0%
49.6%
Q3 25
9.3%
Q2 25
11.3%
Q1 25
9.8%
Q4 24
8.4%
47.8%
Q3 24
11.1%
Q2 24
9.6%
Capex Intensity
AIT
AIT
DOC
DOC
Q1 26
1.5%
Q4 25
0.5%
124.4%
Q3 25
0.6%
Q2 25
0.7%
Q1 25
0.6%
Q4 24
0.5%
105.6%
Q3 24
0.5%
Q2 24
0.6%
Cash Conversion
AIT
AIT
DOC
DOC
Q1 26
3.20×
Q4 25
1.05×
10.99×
Q3 25
1.18×
Q2 25
1.36×
11.48×
Q1 25
1.23×
6.52×
Q4 24
1.02×
235.43×
Q3 24
1.39×
3.71×
Q2 24
1.15×
2.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons